E-LIB Suche - Ergebnisse für: Ruey-Long Hong

1

Betel-nut chewing does not influence PD-L1 expression rates..:

Hong, Ruey-Long ; Yen, Chia-Jui ; Lien, Ming-Yu...
Oral Oncology. 152 (2024) - p. 106760 , 2024

Link: https://doi.org/10.1016/..

2

Clinical decision pathway and management of locally advance..:

Guo, Ye ; Nakashima, Torahiko ; Cho, Byoung Chul...
Oral Oncology. 148 (2024) - p. 106657 , 2024

Link: https://doi.org/10.1016/..

3

Sequential multimodal treatments with chemotherapy and surg..:

Chen, Ching-Tso ; Chen, Hsing-Wu ; Lin, Wei-Hsin...
Journal of the Formosan Medical Association. , 2024

Link: https://doi.org/10.1016/..

4

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-..:

Lim, Darren Wan-Teck ; Kao, Hsiang-Fong ; Suteja, Lisda...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

A Phase 1b/2 Study of Alpelisib in Combination with Cetuxim..:

Razak, Albiruni R. Abdul ; Wang, Hung-Ming ; Chang, Jang-Yang...
Targeted Oncology. 18 (2023) 6 - p. 853-868 , 2023

Link: https://doi.org/10.1007/..

6

Role of chemotherapy in patients with nasopharynx carcinoma..:

Petit, Claire ; Lee, Anne ; Ma, Jun...
The Lancet Oncology. 24 (2023) 6 - p. 611-623 , 2023

Link: https://doi.org/10.1016/..

7

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-..:

Darren Wan-Teck Lim ; Hsiang-Fong Kao ; Lisda Suteja...
https://doi.org/10.1038/s41467-023-38407-7. , 2023

Link: https://doi.org/10.1038/..

8

Afatinib and Pembrolizumab for Recurrent or Metastatic Head..:

Kao, Hsiang-Fong ; Liao, Bin-Chi ; Huang, Yen-Lin...
Clinical Cancer Research. 28 (2022) 8 - p. 1560-1571 , 2022

Link: https://doi.org/10.1158/..

9

Short-course pembrolizumab and continuous afatinib therapy ..:

Kao, Hsiang-Fong ; Huang, Huai-Cheng ; Liao, Bin-Chi.
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

10

Posterior Reversible Encephalopathy Syndrome after Lenvatin..:

Tseng, Yu-Ju ; Chen, Chun-Nan ; Hong, Ruey-Long..
Brain Sciences. 13 (2022) 1 - p. 33 , 2022

Link: https://doi.org/10.3390/..

11

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC..:

Blanchard, Pierre ; Lee, Anne W.M. ; Carmel, Alexandra...
Clinical and Translational Radiation Oncology. 32 (2022) - p. 59-68 , 2022

Link: https://doi.org/10.1016/..

12

Pembrolizumab alone or with chemotherapy for recurrent or m..:

Rischin, Danny ; Harrington, Kevin J. ; Greil, Richard...
Oral Oncology. 128 (2022) - p. 105815 , 2022

Link: https://doi.org/10.1016/..

13

Posterior Reversible Encephalopathy Syndrome after Lenvatin..:

Yu-Ju Tseng ; Chun-Nan Chen ; Ruey-Long Hong..
https://dx.doi.org/10.3390/brainsci13010033. , 2022

Link: https://doi.org/10.3390/..

14

Posterior Reversible Encephalopathy Syndrome after Lenvatin..:

Yu-Ju Tseng ; Chun-Nan Chen ; Ruey-Long Hong..
https://www.mdpi.com/2076-3425/13/1/33. , 2022

Link: https://doi.org/10.3390/..

15

Short-course pembrolizumab and continuous afatinib therapy ..:

Hsiang-Fong Kao ; Huai-Cheng Huang ; Bin-Chi Liao.
https://doi.org/10.1186/s12885-022-10343-7. , 2022

Link: https://doi.org/10.1186/..